This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 11 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Hoffmann-La Roche Inc.. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rockville, MD (US) (2008 - 2019)
- Germantown, MD (US) (2022 - 2023)
Company Filing History:
14 out of 3,696 
1 out of 5,026 
Years Active: 2008-2025
Title: **Masanori Onda: A Pioneer in Immunotoxin Development**
Introduction
Masanori Onda, based in Rockville, MD, is an accomplished inventor with a notable portfolio comprising 14 patents. His innovations primarily focus on the development of advanced therapeutic molecules, particularly in the field of cancer treatment. His contributions to the biomedical field demonstrate a profound understanding of molecular biology and therapeutic applications.
Latest Patents
One of Masanori Onda's latest patents involves the design of immunotoxins with an albumin binding domain. This innovative molecule consists of several key components: a targeting moiety, an albumin binding domain (ABD), a furin cleavage sequence (FCS) that is cleavable by furin, and an optionally substituted Domain III from exotoxin A (PE). The patent also includes related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions. Furthermore, it presents methodologies for producing this molecule, along with methods aimed at treating or preventing cancer in mammals and inhibiting the growth of target cells.
Career Highlights
Throughout his career, Masanori Onda has collaborated with prominent institutions, including the United States of America as represented by the Secretary of the Department of Health and Human Services and Hoffmann-La Roche Inc. His work has significantly advanced the medicinal chemistry field, especially in terms of designing effective cancer therapeutics.
Collaborations
Masanori has worked alongside esteemed colleagues like Ira H. Pastan and Wenhai Liu. These collaborations underscore his commitment to interdisciplinary research and innovation, allowing him to leverage diverse expertise in his projects, resulting in impactful biomedical advancements.
Conclusion
Masanori Onda stands out as a key figure in the realm of immunotoxin development, with a focus on groundbreaking solutions for cancer treatment. His patent portfolio and collaborations highlight his influential role in advancing medical technology, making significant strides toward improving therapies in the healthcare landscape. As the field of biomedicine continues to evolve, Masanori Onda's work will undoubtedly leave a lasting legacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile